Selinexor Combined With Ruxolitinib Shows Promising Results in Patients With MF and Poor Ruxolitinib | Blood Cancers Today
Combined with the exporter-1 inhibitor, selinexor, ruxolitinib reduces spleen volume and reduces symptoms for participants with MF who did not respond well to JAK inhibitors.